Prostate cancer, insulin, and androgen deprivation therapy
- PMID: 14583790
- PMCID: PMC2394411
- DOI: 10.1038/sj.bjc.6601351
Prostate cancer, insulin, and androgen deprivation therapy
Comment on
-
Serum insulin level, disease stage, prostate specific antigen (PSA) and Gleason score in prostate cancer.Br J Cancer. 2002 Sep 23;87(7):726-8. doi: 10.1038/sj.bjc.6600526. Br J Cancer. 2002. PMID: 12232754 Free PMC article.
References
-
- Fukui M, Koyama M, Nakagawa Y, Itoh Y, Nakamura N, Kondo M (2000) Castration and diabetes. Diabetes Care 23: 1032–1033 - PubMed
-
- Haffner SM, Valdez RA, Mykkanen L, Stern MP, Katz MS (1994) Decreased testosterone and dehydroepiandrosterone sulfate concentrations are associated with increased insulin and glucose concentrations in nondiabetic men. Metabolism 43: 599–603 - PubMed
-
- Hsing AW, Chua Jr S, Gao YT, Gentzschein E, Chang L, Deng J, Stanczyk FZ (2001) Prostate cancer risk and serum levels of insulin and leptin: a population-based study. J Natl Cancer Inst 93: 783–789 - PubMed
-
- Jansson PA, Eliasson B, Lindmark S, Eriksson JW (2002) Endocrine abnormalities in healthy first-degree relatives of type 2 diabetes patients–potential role of steroid hormones and leptin in the development of insulin resistance. Eur J Clin Invest 2002: 172–178 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
